ArticleJournal of Cancer2023

Efficacy and Safety Analysis of Immune Checkpoint Inhibitors plus Angiogenesis Inhibitors for the Treatment of Advanced Driver-negative NSCLC in Elderly Patients: A Retrospective Study.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.